Patents by Inventor Giovanni Buzzi

Giovanni Buzzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins
    Patent number: 6730664
    Abstract: A pharmaceutical formulation which comprises a parenterally acceptable carrier or diluent, estramustine phosphate and a sulfoalkyl ether cyclodextrin. The formulation can be administered according to a combined chemotherapy regimen in association with one or more chemotherapeutic agents. The formulation also enables estramustin phosphate to be administered with no side effects at the site of injection.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: May 4, 2004
    Assignee: Pharmacia Italia S.p.A.
    Inventors: Lorena Muggetti, Paolo Colombo, Alessandro Martini, Giovanni Buzzi
  • Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals
    Publication number: 20040014693
    Abstract: The present invention relates to the use of arginine and, more in particular, to the injectable formulations for intravenous use comprising it, in the prevention and treatment of the side effects associated with the extravasation of drugs administered by intravenous route.
    Type: Application
    Filed: July 14, 2003
    Publication date: January 22, 2004
    Inventors: Lorena Muggetti, Alessandro Martini, Giovanni Buzzi, Paolo Colombo
  • Estramustine formulations with improved pharmaceutical properties
    Patent number: 5712260
    Abstract: The present invention provides a pharmaceutical composition comprising an estramustine derivative and a cyclodextrin, particularly in the manufacture of a medicament suitable for the oral administration of an estramustine derivative to a patient suffering from a tumor.Estramustine derivatives according to the invention are, for example, compounds of general formula (I) ##STR1## wherein R is ##STR2## in which R.sub.1 is C.sub.1 -C.sub.4 alkyl and n is 0, 1 or 2, and the pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: January 27, 1998
    Assignee: Pharmacia AB
    Inventors: Alessandro Martini, Giuseppe Maccari, Lorena Muggetti, Giuseppe Colombo, Giovanni Buzzi